nach oben

Erschienen in:

04.06.2016 | Original Article

Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction

verfasst von: Thorsten Bach, Felix Wölbling, Andreas J. Gross, C. Netsch, S. Tauber, Tobias Pottek, Christian Wülfing, Claus Brunken

Erschienen in: World Journal of Urology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

TUR-prostate (TUR-P) is considered the reference method for surgical treatment of benign prostatic obstruction (BPO); Greenlight laser photoselective vaporization (PVP) and thulium laser vapoenucleation (ThuVEP) have also been established as treatments of BPO. Objective of this prospective observation was to compare a large numbers of patients treated in everyday routine.

Methods

This prospective multicentre data collection assesses morbidity and perioperative course of consecutive men treated with BPO-related transurethral surgery between 2011 and 2014 in a German metropolis area with TUR-P, PVP or ThuVEP.

Results

Two thousand six hundred and forty-eight patients have been treated in the time period. All treatment options achieved immediate improvement of voiding parameters. Multivariate analyses proved shorter hospital stay after laser treatments as compared to resection (p < 0.001). In terms of hospital stay, the advantage of ThuVEP compared to TUR-P increased with prostate volume (p < 0.001). Patients with ongoing anticoagulation or bridging had prolonged hospital stay (p < 0.001). Overall adverse events were least frequent in PVP (p 0.016), as were Clavien 3b events (p < 0.001).

Conclusions

Surgical treatment of BPO is effective and safe independent of the surgical procedure. Volume reduction is most effective in ThuVEP; PVP has the lowest rate of severe complications. Laser treatment is associated with shorter hospital stay. Surgery under ongoing anticoagulation prolonged the post-operative hospital stay.

Gravas S, Bach T; Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO, Karavitakis M, Malde S, Sakkalis V, Umbach R (2016) EAU guidelines in treatment of non-neurogenic male LUTS. www.uroweb.org. 20th March 2016

Thomas JA, Tubaro A, Barber N, Dáncona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Amaye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shroti N, Grahim S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Bachmann A (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr. outcomes of the GOLIATH study. Eur Urol 69:94–102CrossRefPubMed

Netsch C, Engbert A, Bach T, Gross AJ (2014) Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 32:1551–1558CrossRefPubMed

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral

Mitropoulos D, Artibani W, Graefen M, Remzi M, Roupret M, Truss M (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU Guidelines panel assessment and recommendations. Eur Urol 61:341–349CrossRefPubMed

Bach T, Netsch C, Pohlmann L, Herrman TR, Gross AJ (2010) Thulium:YAG laser enucleation in large volume prostates. J Urol 186:2323–2327CrossRef

Bachmann A, Tubaro A, Barber N, Dácona F, Muir G, Witzsch U, Grimmm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Amaye F, Saussine C, Bruyére F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shroti N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Thomas AJ, The GOLIATH study (2014) 180-W XPS Greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of e European multicentre rendomised trail. Eur Urol 65:931–942CrossRefPubMed

Cornu JN, Ahyai SA, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed

Yang Z, Wang X, Liu T (2013) Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology 81:396–401CrossRefPubMed

10.

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397CrossRefPubMed

11.

Netsch C, Tiburtius C, Bach T, Knipper S, Gross AJ (2014) Association of Prostate size and perioperative morbidity in thulium:YAG vapoenucleation of the prostate. Urol Int 93:22–28PubMed

12.

Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63:859–867CrossRefPubMed

13.

Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10654 patients. J Urol 180:246–249CrossRefPubMed

14.

Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 64:306–310CrossRefPubMed

15.

Adam C, Hofstetter A, Deubner J et al (2004) Retropubic transvesical prostatectomy for significant prostatic enlargement must remain a standard part of urology training. Scand J Urol Nephrol 38:472–476CrossRefPubMed

16.

Serrat V, Morgia G, Fondacaro L et al., members of the Sicilian Calabrian Society of Urology (2002) Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology 60:623–627

Titel: Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction
verfasst von: Thorsten Bach
Felix Wölbling
Andreas J. Gross
C. Netsch
S. Tauber
Tobias Pottek
Christian Wülfing
Claus Brunken
Publikationsdatum: 04.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 2/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-016-1866-7

Neu im Fachgebiet Urologie

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction